Blog

Fundraising News

Forbion raises €2.3 billion across two new funds

Forbion raised €2.3 billion ($2.6 billion) across its latest fundraising, marking the largest raise in the firm’s history and one of the largest global life sciences venture capital fundraisings over the past five years. The fundraising substantially exceeded its target, strengthening Forbion’s position as Europe’s largest dedicated life sciences venture capital firm, with approximately €7.5 billion in assets under management. The capital will be deployed through Forbion Growth Opportunities Fund IV and Forbion Ventures Fund VIII, which together can finance approximately 30 high-potential portfolio companies. The first investments have already been completed. Investors included MN, PGGM, KfW Capital, Ewing Marion Kauffman Foundation and Eli Lilly

deals

BDT & MSD Partners to Acquire Sunrise Senior Living from PSP Investments | Investissements PSP

Funds affiliated with BDT & MSD Partners have entered into a definitive agreement to acquire Sunrise Senior Living from the Public Sector Pension Investment Board (PSP Investments), partnering with Sunrise’s senior leadership team, led by CEO Jack R. Callison, Jr.. Sunrise operates more than 230 senior living communities across the United States and Canada, serving over 22,000 residents, with a development pipeline of more than 50 communities representing approximately $7.5 billion in expected development costs. BDT & MSD brings experience investing in and operating real estate, hospitality and residential businesses, including Greystar, Auberge Collection and The Boca Raton. Jack R. Callison, Jr., CEO of Sunrise Senior Living, said: “We are excited to build on that progress with BDT & MSD as our majority investor, whose long-term approach and deep experience across hospitality, development, and real estate operations will complement our team’s expertise and help accelerate Sunrise’s next phase of growth.” Coburn Packard, Head of Real Estate Equity at BDT & MSD Partners, said: “Sunrise is a category-leading business with an exceptional leadership team, trusted brand, and proven operating platform.” Simon

Fundraising News

Taurus Private Markets, LLC Closes $301 Million Oversubscribed Private Equity Fund

Taurus Private Markets closed its third fund, Taurus Private Markets Fund III, LP, with over $300 million in capital commitments, exceeding its initial $225 million target. The oversubscribed fund attracted commitments from public pension plans, Taft-Hartley plans and family offices. The Pennsylvania-based firm invests in value-oriented, lower middle-market leveraged buyout and private credit partnerships with target fund sizes below $1.25 billion. The firm also invests in blue-chip venture capital partnerships targeting funds below $750 million. Its fund-of- funds strategy is complemented by co-investments in privately held companies

Fundraising News

Spectrum Equity Closes Oversubscribed $2.5 Billion Fund XI

Spectrum Equity closed its 11th fund, Fund XI, at $2.5 billion, in an oversubscribed, single close. Fund XI is the firm’s largest fund since its founding in 1994. Investment focus: rapidly growing, capital-efficient, founder-led companies across software, artificial intelligence and data services. The firm will seek to partner with exceptional management teams to build durable competitive advantages, particularly amid rapid AI-driven innovation and competitive pressures. Spectrum has 78 employees and 48 active portfolio companies, providing hands-on support and industry expertise. Fund XI attracted long-standing limited partners as well as new investors. More than 50 investors are founders, executives or board members of Spectrum portfolio companies. Ben Spero, Managing Director: “Over the last 30

Fundraising News

Consonance Capital Partners Closes Oversubscribed Third Fund at $1.35 Billion

Fund size: $1.35 billion in total commitments for Consonance Private Equity III, L.P. (Fund III). Final close: Reached its $1.35 billion hard cap in a heavily oversubscribed process. Fundraising timeline: Closed in just under four months. Investment strategy: Focused on lower and middle-market U.S. healthcare companies. Investor base: Strong support from existing LPs, alongside a select group of new investors. Investor profile: Diverse global mix of endowments and foundations, pension plans, and financial institutions. Fund strategy: Continues the approach of its predecessor funds, partnering with high-quality management teams to build businesses delivering sustainable value through high-quality, cost-effective healthcare. Mitchell Blutt, MD, Nancy-Ann DeParle, Benjamin Edmands,